An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)
This study is currently recruiting participants.
Verified December 2011 by Active Biotech AB
Sponsor:
Active Biotech AB
Information provided by (Responsible Party):
Active Biotech AB
ClinicalTrials.gov Identifier:
NCT01487551
First received: December 6, 2011
Last updated: March 7, 2012
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |